Surgepays Q2 EPS $0.40 Vs $(0.08) Last Year, Sales $35.89M Miss $39.05M Estimate
Portfolio Pulse from Benzinga Newsdesk
Surgepays reported Q2 earnings of $0.40 per share, a 600% increase from last year. However, its quarterly sales of $35.89M missed the analyst consensus estimate of $39.05M by 8.10%. Sales increased by 28.14% compared to the same period last year.
August 10, 2023 | 8:14 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Surgepays' Q2 earnings beat last year's figures but sales missed estimates.
Surgepays reported a significant increase in earnings, which is positive for the stock. However, the company missed sales estimates, which could negatively impact the stock. The net effect could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100